Low dehydroepiandrosterone sulfate and heart disease in middle-aged men: Cross-sectional results from the Massachusetts male aging study

被引:69
作者
Feldman, HA
Johannes, CB
McKinlay, JB
Longcope, C
机构
[1] New England Res Inst, Watertown, MA 02172 USA
[2] Univ Massachusetts, Med Ctr, Dept Obstet & Gynecol, Worcester, MA 01605 USA
关键词
aging; androgens; cardiovascular diseases; coronary heart disease; dehydroepiandrosterone; ischemic heart disease; risk factors;
D O I
10.1016/S1047-2797(97)00199-3
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
PURPOSE: Serum concentrations of the adrenal androgen dehydroepiandrosterone (DHEA) and its sulfate ester (DHEAS), both of which decline with age more markedly than other sex hormone levels, have been alternately credited and discredited as "protective" correlates of heart disease. Baseline data from the Massachusetts Male Aging Study (MMAS), collected in 1987-89, provided a large population-based random sample (n = 1709) in which to examine cross-sectionally the relation of DHEA and DHEAS levels to heart disease, while controlling for a comprehensive set of potential confounders including serum lipid and hormone levels as well as smoking, alcohol intake, obesity, hypertension, diabetes, diet, medication, physical activity, and psychological measures. METHODS: The subjects were men aged 40-70 years, randomly sampled from the Massachusetts state census listing, measured and interviewed at home. Nonfasting blood samples were assayed for hormones and lipids. RESULTS: In all strata of age, smoking, and alcohol intake, the age-adjusted odds ratio for self-reported heart disease was between 0.55 and 0.85 per standard deviation (SD) of log DHEA and DHEAS concentration. Multiple logistic regression analysis indicated a strong independent role for DHEAS as a predictor of self-reported heart disease, controlling for age and the potential confounders listed above. The multiply-adjusted odds ratio for heart disease was 0.64 per SD log DHEAS concentration, with 95% confidence interval (CI) 0.50-0.83 (P = 0.0002). The DHEAS effect was not diminished by controlling for use of cardiac, vasodilator, antihypertensive, or lipid-lowering medication. CONCLUSIONS: These findings suggest that serum DHEAS levels bear an inverse relationship to heart disease, independently of a large set of established cardiovascular risk factors. The cross-sectional nature of this study requires that the findings be interpreted with caution. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:217 / 228
页数:12
相关论文
共 92 条
  • [1] DEHYDROEPIANDROSTERONE FEEDING PREVENTS AORTIC FATTY STREAK FORMATION AND CHOLESTEROL ACCUMULATION IN CHOLESTEROL-FED RABBIT
    ARAD, Y
    BADIMON, JJ
    BADIMON, L
    HEMBREE, WC
    GINSBERG, HN
    [J]. ARTERIOSCLEROSIS, 1989, 9 (02): : 159 - 166
  • [2] NUTRIENT INTAKES AND BLOOD-PRESSURE IN NORMOTENSIVE MALES
    ASCHERIO, A
    STAMPFER, MJ
    COLDITZ, GA
    WILLETT, WC
    MCKINLAY, J
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1991, 20 (04) : 886 - 891
  • [3] DEHYDROEPIANDROSTERONE-SULFATE DOES NOT PREDICT CARDIOVASCULAR DEATH IN POSTMENOPAUSAL WOMEN - THE RANCHO-BERNARDO STUDY
    BARRETTCONNOR, E
    GOODMANGRUEN, D
    [J]. CIRCULATION, 1995, 91 (06) : 1757 - 1760
  • [4] BARRETTCONNOR E, 1987, NEW ENGL J MED, V317, P711
  • [5] The epidemiology of DHEAS and cardiovascular disease
    BarrettConnor, E
    GoodmanGruen, D
    [J]. DEHYDROEPIANDROSTERONE (DHEA) AND AGING, 1995, 774 : 259 - 270
  • [6] A PROSPECTIVE-STUDY OF DEHYDROEPIANDROSTERONE SULFATE, MORTALITY, AND CARDIOVASCULAR-DISEASE
    BARRETTCONNOR, E
    KHAW, KT
    YEN, SSC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (24) : 1519 - 1524
  • [7] BARRETTCONNOR E, 1990, BIOL ROLE DEHYDROEPI, P281
  • [8] DISPARATE EFFECTS OF INSULIN REDUCTION WITH DILTIAZEM ON SERUM DEHYDROEPIANDROSTERONE-SULFATE LEVELS IN OBESE HYPERTENSIVE MEN AND WOMEN
    BEER, NA
    JAKUBOWICZ, DA
    BEER, RM
    NESTLER, JE
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (04) : 1077 - 1081
  • [9] Dehydroepiandrosterone reduces plasma plasminogen activator inhibitor type 1 and tissue plasminogen activator antigen in men
    Beer, NA
    Jakubowicz, DJ
    Matt, DW
    Beer, RM
    Nestler, JE
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1996, 311 (05) : 205 - 210
  • [10] EFFECTS OF NITRENDIPINE ON GLUCOSE-TOLERANCE AND SERUM-INSULIN AND DEHYDROEPIANDROSTERONE SULFATE LEVELS IN INSULIN-RESISTANT OBESE AND HYPERTENSIVE MEN
    BEER, NA
    JAKUBOWICZ, DJ
    BEER, RM
    AROCHA, IR
    NESTLER, JE
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (01) : 178 - 183